Innovations in Biomedical Nanoscience
Keywords:
Biomedical Nanoscience, Nanoparticle-Based Drug Delivery, Nanoscale Diagnostics, Nanomaterials, Regenerative Medicine, Tissue EngineeringAbstract
Biomedical nanoscience is a transformative field at the intersection of nanotechnology and biomedical sciences, offering innovative approaches to diagnosis, treatment, and regenerative medicine. This review explores recent advancements in nanoparticle-based drug delivery systems, nanoscale diagnostics, and the use of nanomaterials in regenerative medicine. It highlights the diverse types of nanoparticles such as liposomes, polymeric nanoparticles, metallic nanoparticles, and dendrimers, each tailored for specific therapeutic applications including cancer therapy, cardiovascular diseases, and infectious diseases. The review also delves into the cutting-edge development of nano biosensors and point-of-care diagnostics that utilize quantum dots, gold nanoparticles, and carbon nanotubes to enhance sensitivity and specificity. Furthermore, it examines the role of nanofibers and scaffolds in tissue engineering and stem cell engineering for regenerative medicine. Despite the promising advancements, the review underscores the importance of addressing challenges related to toxicity, biocompatibility, and regulatory approval to fully realize the potential of nanomedicine in clinical settings.
References
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nano-enabled medical applications. 2020 Nov 23:61-91.
Mitragotri S. The launch phase of Bioengineering & Translational Medicine. Bioengineering & Translational Medicine. 2019 Sep;4(3).
Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine—challenge and perspectives. Angewandte Chemie International Edition. 2009 Jan 19;48(5):872-97.
Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics. 2009 Mar 1;71(3):431-44.
Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. Pharmacy and Therapeutics. 2017 Dec;42(12):742.
Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annual review of medicine. 2012 Feb 18;63:185-98.
Published
Issue
Section
Copyright (c) 2024 Journal of Advanced Research in Nanoscience and Nanotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
